<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), an age-related disease, is the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the world </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, that affects 80-85% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients, is a multi-step process initiated by APC gene mutation, it is becoming increasingly evident that a small sub-population of cells termed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem/stem-like cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>/CSLCs) plays critical roles in the progression of this <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> specially the recurrence and drug resistance </plain></SENT>
<SENT sid="2" pm="."><plain>The current review will summarize genetic and epigenetic changes observed at different stages in the progression of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, roles of miRNAs that control gene expression and <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>/CSLCs in regulating proliferation, differentiation, and survival of the <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells will be summarized </plain></SENT>
</text></document>